13-hydroxy-9-11-octadecadienoic-acid has been researched along with glycyl-arginyl-glycyl-aspartyl-serine* in 1 studies
1 other study(ies) available for 13-hydroxy-9-11-octadecadienoic-acid and glycyl-arginyl-glycyl-aspartyl-serine
Article | Year |
---|---|
Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression.
Previously, we have demonstrated that stimulation of endothelial cells (ECs) with interleukin-1 alpha (IL-1 alpha) enhances the synthesis and expression of the vitronectin receptor (VnR), promotes VnR-dependent adhesion of human A549 adenocarcinoma cells to ECs, and is associated with decreased EC 13-hydroxyoctadecadienoic acid (13-HODE) synthesis in vitro. To determine whether these observations are relevant in vivo, we examined the acute retention and subsequent metastasis of intravenously-injected B16F10 melanoma cells in murine lungs, in relation to vessel wall 13-HODE. In C57BL/6 mice pretreated with IL-1 alpha, vessel wall 13-HODE was decreased and B16F10 lung entrapment and metastasis were increased. The latter two events were blocked by pretreating the animals with the GRGDS peptide. These data suggest a relationship between vessel wall 13-HODE synthesis, adhesion molecule expression, and adhesion of B16F10 cells to the endothelium. Topics: Animals; Cell Adhesion; Down-Regulation; Endothelium, Vascular; Interleukin-1; Linoleic Acids; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Oligopeptides; Receptors, Cytoadhesin; Receptors, Vitronectin; Recombinant Proteins | 1993 |